There exist at least two major coreceptors for human immunodeficiency virus (HIV)-1 entry into target cells, the CXCR-4 and CCR-5 chemokine receptors for T lymphocyte-tropic and macrophage-tropic strains of HIV-1, respectively. Highly purified human CD34 cells derived from umbilical cord blood were shown not to express CD4, CXCR-4, and CCR-5 on their cell membranes, as analyzed by immunofluorescent staining and flow cytometric analyses. However, expression of these molecules was inducible when highly purified CD34 cells underwent proliferation and differentiation along myeloid cell lineages, in the presence of suitable cocktails of hematopoietic growth factors. HIV-1 infectivity studies showed that macrophagetropic strains of HIV-1 could efficiently infect differentiated CD34 cells. T lymphocyte-tropic strains could not infect CD34 cells before or after induction of receptors and coreceptors. These data suggest that HIV-1 infection of CD34 cells and their progeny depends on membrane expression of the critical CD4 receptor, as well as certain chemokine coreceptors.
action of viral envelope with chemokine coreceptors has also been demonstrated, and fusion occurs only if the intact V 3 loop is present in the envelope glycoprotein [13] . Cocchi et al. [14] demonstrated that the V 3 domain of the HIV-1 gp120 envelope glycoprotein is critical in the chemokine-mediated blockade of infection. Therefore, the V 3 loop must be a key factor in HIV-1 not only to determine the cellular tropism but also to specify receptor usage and chemokine blockade of infection.
Studies of HIV-1 target cells have demonstrated that the CD4 cell membrane receptor for HIV-1, and coreceptors, are essential for HIV-1 infection. The human T lymphocyte CD4 molecule was the first cellular element to be recognized as a key receptor for both HIV-1 and HIV-2 entry [15, 16] . However, subsequent studies proved that CD4 alone was insufficient for the viral envelope glycoprotein-induced fusion with cell membranes, as certain murine cells expressing human CD4 could not be infected with HIV-1 [17] [18] [19] , suggesting that speciesspecific molecules or cofactors must be involved in HIV-1 infection. Recent breakthroughs in the field of HIV-1 studies have demonstrated that a-and b-chemokine receptors CXCR-4 (also known as fusin, LESTR, or HUMSTR) and CCR-5, respectively, are major coreceptors for T-tropic and M-tropic strains of HIV-1, respectively. Both of these two coreceptor moieties (seven-transmembrane GTP-binding protein-coupled), with high genetic homology, were identified from the a-and b-chemokine receptor superfamily [4, 20, 21] . Human cells expressing CD4, CXCR-4, and CCR-5 demonstrated that these two coreceptors allow fusion with the viral envelope protein, which depends on the expression of CD4, although the CCR-5 co-receptor for M-tropic virus entry requires only trace quantities of CD4 [22, 23] . This might be due to cooperative function between CCR-5 and other coreceptors for M-tropic HIV-1 entry, such as CCR-3 and CCR-2b [24, 25] .
HIV-1 infects T lymphocytes, monocyte/macrophages, dendritic cells, and microglial cells in vitro and in vivo [1, [26] [27] [28] . Further molecular factors involved in HIV-1 infection of these cells, in addition to CD4, have been demonstrated recently, as monocyte/macrophages and macrophage-depleted T lymphocyte fractions from peripheral blood mononuclear cells express the b-chemokine coreceptor CCR-5 [20] . Monocytes and lymphocyte subsets, including B lymphocytes, express the a-chemokine coreceptor CXCR-4 [29] . Dendritic cells may express CCR-5 and CXCR-4 [30, 31] , demonstrated by b-chemokine blockage of M-tropic virus entry and stromal-derived factor (SDF)-1 blockade of T-tropic virus entry [30] . Of note, microglial cells express both CCR-3 and CCR-5 [32] . Chemokines, which are found in CD8 T lymphocyte culture supernatants and may be a portion of the suppressor factors of HIV-1 infection [33] , are potential reagents for the treatment of HIV-1 infections by interfering with the binding of virus to a suitable cellular coreceptor [34, 35] . The ligand for CXCR-4, SDF-1, and a related chemokine antagonist have proved to have similar inhibitory effects on HIV-1 fusion and entry [36, 37] .
Chemokines that are ligands for receptors, which are used as fusion cofactors, may play a role in modulating the activity of hematopoietic stem cells (HSC), thus implying that their receptors are expressed by these cells. While macrophage inhibitory protein-1a may exert a negative influence on HSC proliferation and differentiation, SDF-1, the ligand for CXCR-4, may promote these functions [38] .
HSC, which produce blood cells of all lineages, including two main cellular populations for HIV-1 infection, CD4 T lymphocytes and monocyte/macrophages, may be involved in many of the cytopenias occurring at the late stages of AIDS. Several adverse factors have been hypothesized to have suppressing effects on hematopoiesis or to induce apoptosis of stem cells [39] [40] [41] [42] . It is important to note that direct HIV-1 infection of HSC or their progenitor cells is still controversial [43] [44] [45] [46] [47] . In light of recent findings that CXCR-4 and CCR-5 act as two important coreceptors for T-tropic and M-tropic strains of HIV-1 entry, analyses of these moieties expressed on HSC or their cellular progeny, and the dynamic interactions with HIV-1, would be helpful for understanding HIV-1 pathogenesis in vivo and possibly for improving treatment options for patients with AIDS.
Materials and Methods

Human umbilical cord blood (UCB).
Heparin-anticoagulated, fresh human UCB, obtained from healthy, HIV-1-seronegative persons in the delivery room of Thomas Jefferson University Hospital, was used for these studies.
Antibodies. Directly labeled (with R-phycoerythrin) mouse IgG and monoclonal antibodies against CD4 and CD34-HPCA-2 (Becton Dickinson, Lincoln Park, NJ) were used for the analysis of CD4 and CD34 expression. Mouse hybridomas producing monoclonal antibodies against the Vif protein of HIV-1 (provided by M. Malim, University of Pennsylvania), CXCR-4 (12G5), and CCR-5 (12D1) were used for the analysis of CXCR-4 and CCR-5 expression. The secondary antibody, goat anti-mouse IgG conjugated with Cy2, was purchased from Biological Detection Systems (Pittsburgh); 1:500-diluted solutions of antibodies were used in these experiments.
Hematopoietic growth factors (HGFs). Recombinant human stem cell factor and recombinant human interleukin-3 (IL-3) and IL-6 were purchased from R&D Systems (Minneapolis). Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) and recombinant macrophage colony-stimulating factor (M-CSF) were purchased from Gibco BRL (Gaithersburg, MD). All HGFs were reconstituted according to the manufacturer's instructions, aliquoted, and stored at Ϫ80ЊC.
Enrichment of CD34 cells from human UCB. Fresh, heparinized human UCB (30-50 mL), from HIV-1-seronegative mothers and children, was diluted with equal volumes of 0.5% bovine serum albumin (BSA)-5 mM EDTA-PBS, loaded carefully on the top of a Histopaque solution (Sigma, St. Louis; density, 1.077), and centrifuged at 2000 rpm at room temperature for 20 min. The cells in the interface were removed and washed with PBS buffer at 4ЊC, twice. The pellet was resuspended with PBS, 300 mL for 8 1 ϫ 10 nucleated cells, and incubated with 100 mL of reagent A1 plus 100 mL of reagent A2 from the CD34 isolation kit (Miltenyi Biotech, Auburn, CA) at 4ЊC for 15 min. After washing with 5 mL of PBS, the cell pellet was resuspended with 400 mL of PBS and incubated with 100 mL of reagent B at 4ЊC for 15 min. After washing with 5 mL of PBS, the cells were resuspended with 400 mL of PBS and loaded onto a prebalanced MiniMACS column (Miltenyi Biotech), according to the protocol provided by the manufacturer. To obtain stringently purified CD34 cell populations, the cell suspension collected from the first column was reloaded onto the second column. The final eluted cells were washed with PBS and resuspended in culture medium.
Induction of CD34 cells into proliferation and differentiation along the myeloid cell lineage. The highly purified CD34 cells were resuspended with 10% fetal bovine serum (FBS)-Dulbecco's MEM (DMEM) culture medium containing different concentrations of specific HGFs: IL-3, IL-6, and stem cell factor (10 ng/mL each) and GM-CSF and M-CSF (25 ng/mL each). The cells were cultured in an incubator containing 5% CO 2 in air at 37ЊC. The maximum cell concentrations were maintained at 1.0-/mL. The cells (3- ) to be analyzed were washed with 0.2% BSA-PBS twice, 4 4 ϫ 10 resuspended in 100 mL of BSA-PBS, and incubated with 10 mL of directly labeled (with R-phycoerythrin) mouse IgG or specific antibodies against human CD34 (anti-HPCA-2) or CD4 at 4ЊC for 30 min. After being washed with BSA-PBS twice, the cells were resuspended in 20% formaldehyde for flow cytometric analysis. For analysis of CCR-5 and CXCR-4 expression, the cells in 100 mL of Immunofluorescent microscopic analyses. Immunofluorescent microscopic analyses were done as described previously [48] . After staining 100 mL of the cell suspension containing cells, the 4 4 ϫ 10 cells were centrifuged at 800 rpm using Cytospin (Shandon Scientific, UK) to prepare the slide for examination of immunostained cells by epifluorescence microscopy.
Reverse transcription-initiated polymerase chain reaction (RT-PCR). Cells (1-
) were lysed in 1.0 mL of Ultraspec RNA 6 2 ϫ 10 (Biotecx Laboratories, Houston). After homogenization, the homogenate was maintained for 5 min at 4ЊC, 0.2 mL of chloroform was added, and the mixture was shaken vigorously for 15 s and placed on ice at 4ЊC for 5 min. The homogenate was centrifuged at 16,000 g for 15 min. The aqueous phase was removed and added into a new tube. Equal volumes of isopropanol were added and maintained for 10 min at Ϫ20ЊC. The samples were centrifuged at 16,000 g for 10 min at Ϫ20ЊC, the supernatant was removed, and the RNA pellet was washed twice with 75% ethanol by vortexing and subsequent centrifugation for 5 min at 7500 g. The pellet was dried under a vacuum for 5-10 min. The RNA pellet was dissolved in 50-100 mL of Ultraspec diethyl pyrocarbonate-treated water. RT reactions were carried out by adding 1 mg of RNA, using a standard reaction system, primed by random primers at 37ЊC for 1 h [49] .
A standard PCR reaction protocol was used for the in vitro amplification of CCR-5, CXCR-4, CD34, CD4, and b-actin cDNA [49] . The specific primers for cDNAs were as follows: for CCR-5 The PCR reactions consisted of 40 cycles of denaturation at 94ЊC for 1 min, annealing at 50ЊC for 1 min, and extension at 72ЊC for 2 min. The samples were analyzed by autoradiography on 1% agarose gels with ethidium bromide staining.
Viral challenge of highly purified CD34 cells and their differentiated cellular progeny. Cells ( /400 mL) were added to a 5 4 ϫ 10 sterile tube and incubated with either 100 mL or 10 mL of HIV-1 BaL (10 ng or 1 ng of HIV-1 p24 antigen equivalents) or 10 mL of HIV-1 NL4-3 (10 ng of HIV-1 p24 antigen equivalents) (both obtained from AIDS Reagent Repository, NIH, Bethesda, MD) in an incubator with 5% CO 2 in air at 37ЊC for 4 h. BaL is a well-characterized M-tropic strain, while NL 4-3 is a T-tropic strain of HIV-1 [50] . Of note, both NL 4-3 and BaL preparations led to robust replication in primary blood lymphocytes and macrophages, respectively (∼40 ng/mL HIV-1 p24 antigen) [51] . After washing with 14 mL of RPMI 1640 three times, the cells were resuspended with 10% FBS-DMEM containing IL-3, IL-6, and stem cell factor (10 ng/mL each) plus GM-CSF and M-CSF (25 ng/mL each) for further cultivation, after challenge with these M-tropic and T-tropic strains of HIV-1. The cell line PM1 (AIDS Reagent Repository, NIH) was challenged with both viruses (1 ng of HIV-1 p24 antigen equivalents) as a positive control for day 0 highly purified CD34 cells. PM1 cells have been demonstrated to be infectible with both M-and T-tropic strains of HIV-1 [52] . The culture supernatants were collected every week and stored at Ϫ20ЊC for HIV-1 p24 antigen analyses in batches. HIV-1 p24 antigen analyses were done by use of the DuPont (Wilmington, DE) ELISA system.
Results
Characterization of purified CD34 cells from UCB.
Under normal conditions, the percentage of CD34 stem cells in different hematopoietic organs is extremely low. We have chosen human UCB as a convenient source of CD34 cells. Of note, unlike peripheral blood CD34 cells from patients treated with chemotherapeutic agents, UCB-derived CD34 cells represent a natural, undisturbed population of stem cells. A reproducibly high recovery of CD34 cell populations (0.5-) with a 6 1.0 ϫ 10 purity of 195% could be obtained from 50 mL of cord blood by use of the MiniMACS columns and the CD34 cell isolation kit (Miltenyi Biotech) for enrichment of CD34 cells (figure 1). This highly purified CD34 cell population possessed a very strong proliferative ability when the isolated cells were cultured in a liquid culture system containing 10% FBS and a cocktail of HGFs. The cell number increased up to 350-fold after 3 weeks of cultivation. Moreover, the isolated CD34 cells gave rise to high numbers of different hematopoietic colonies when they were inoculated in methylcellulose culture medium (Stem Cell, Vancouver, Canada). The total number of colonies was ∼200/1000 purified CD34 cells (data not illustrated).
In these experiments, we induced the purified CD34 cells into proliferation and differentiation along myeloid cell lineages for further studies. The expression of the CD34 cellular surface marker was also confirmed by fluorescent staining of the purified or induced CD34 cells with the antibody CD34-HPCA-2 and examination with an epifluorescence microscope. Almost all of the purified cell populations before induction expressed the CD34 surface molecule (figure 2). Of note, CD4 was demonstrated on the stem cells only after stimulation with HGFs ( figure 2; see below) .
Transcriptional expression of CD34, CD4, CCR-5, and CXCR-4. HSC or CD34 cells, most in a quiescent state, express only limited quantities of detectable surface markers. A demonstration of CXCR-4 and CCR-5 expression on these cells, which are critical coreceptors for T-tropic and M-tropic HIV-1 entry, respectively, would be important not only for understanding the pathogenesis but potentially for the treatment of AIDS. These studies were designed to determine if highly purified CD34 cells express certain critical moieties as a basis for HIV-1 infection and at which point these cells begin to express these receptors and coreceptors once they are induced into proliferation and differentiation.
To evaluate kinetic changes in CD34, CD4, CCR-5, and CXCR-4 expression at the transcriptional level, we used RT-PCR. These studies (figure 3) demonstrated that the expression patterns of the mRNAs of these four proteins were quite different. CD34 mRNA expression was detected on days 0 and 4 and disappeared by day 8 (note, the specific band for CD34 cDNA is absent on day 8), which implies that the CD34 expression is negatively correlated with CD34 cell proliferation and differentiation. CD4 expression, a cell lineage-specific antigen, could be found at all time points except on day 0, and the expression became stronger after 16 and 20 days of induction (figures 2, 3). Thus, CD4 may be expressed mainly on the terminally differentiated cells. CCR-5 mRNA expression was not present on day 0 but was found on days 4, 8, and 12. This mRNA was no longer detectable after day 12. CXCR-4 expression could be demonstrated from day 0 to day 20. The different patterns of mRNAs of these two chemokine coreceptors suggest that they may be expressed by different subtypes of stem cells or on the same cell population but with different expression levels. In these experiments, b-actin expression was examined as a control to monitor overall mRNA sample quality and relative quantity (figure 3).
Precise quantitation is hindered by the very small samples of cells, which during differentiation are heterogeneous in nature. Of note, varying quantities of cells will be nonadherent and adherent, as they differentiate into macrophages, in the different samples obtained temporally after culture and induction. Thus, this evaluation of multiple different cellular mRNAs is not a quantitative approach and was used to detect presence or absence of the receptors' mRNAs. As such, it is useful in demonstrating gross alterations (over about an order of magnitude) in each of the target mRNAs within cells but not for comparison between different mRNA species. These data demonstrate the general dynamics of CD4, CD34, CXCR-4, and CCR-5 mRNAs during differentiation of HSC.
Cell membrane expression of CD34, CD4, CCR-5, and CXCR-4.
To demonstrate the functional expression of the HIV-1 receptor and coreceptors on highly purified CD34 cells or their cellular progeny, the kinetic changes in expression of these cell markers were monitored, in parallel, by flow cytometric analysis, when CD34 cells underwent proliferation and differentiation along myeloid cell lineages. Figures 4 and 5 are representative results, from which it can be demonstrated that CD34 expression was quickly lost by day 8 after induction in vitro, while the cell lineage-specific marker CD4 and HIV-1 coreceptors CXCR-4 and CCR-5 were gradually increased at differing rates. These results demonstrate that the highly purified CD34 cells, before induction, do not express receptors and coreceptors for HIV-1 entry but that their expression is inducible. In comparison with the expression of the CD4 moiety, CXCR-4 and CCR-5 protein expression occurred significantly earlier and to higher levels. These findings were reproducible in several experiments, although some differences in percentages of positive cells between independent experiments could be observed ( figures 4, 5) . Of note, the inducible expression of CCR-5 and CXCR-4 was also examined by immunofluorescent staining and epifluorescence microscopy, in addition to fluorescenceactivated cell sorting. CD34 cell progeny, induced after 12 days with HGFs, revealed membrane expression of CXCR-4 and CCR-5, while uninduced CD34 cells were always negative for these chemokine receptors (figure 4).
Because our in vitro induction system allows CD34 cells to produce different cell types of the macrophage lineage (data not shown), the types of cells expressing coreceptors for HIV-1 entry were morphologically demonstrated by immunofluorescent staining of day 12-differentiated cells with specific antibodies to CXCR-4 and CCR-5 plus fluorescence-activated cell sorting. Of note, predifferentiation HSC demonstrated a mixed cell morphology (not illustrated), as did CXCR-4-and CCR-5-negative cells after differentiation ( figure 6 ). Significant differences in cell morphology between negative and positive cell populations could be easily demonstrated (figure 6). The typical "fried-egg" appearance of differentiated macrophages was demonstrated in the CXCR-4-and CCR-5-positive cells. Previous studies with the HGF cocktail used in these experiments yielded macrophages, but not T lymphocytes, on differentiation, as assessed by marker analyses. Both CXCR-4 and CCR-5 antigens were expressed on CD34 cell-derived macrophages.
HIV-1 challenge of CD34 cells and their cellular progeny.
On the basis of our experimental results of transcriptional and cellular membrane expression of the HIV-1 receptor and co- M-tropic strains of HIV-1 could efficiently infect differentiated CD34 cell-derived cells, if the input challenge virus was at a relatively high dose (10 ng of HIV-1 p24 antigen equivalents), but these differentiated cells were more difficult to infect with lower dosages of input M-tropic virus (e.g., 1 ng of p24 antigen equivalents; figures 7, 8) . From HIV-1 p24 antigen expression assays, it is demonstrated that the level of HIV-1 replication, from different samples derived from various time points after induction, is increased with longer induction time and higher cellular membrane expression of CD4, CCR-5, and CXCR-4 (figures 7, 8) . Of note, although CXCR-4 expression increased on induction, T-tropic strains could not infect CD34 cell-differentiated macrophage/monocytes at any time point.
Discussion
Hematopoietic abnormalities in HIV-1-infected persons may be due to complicated and interacting factors related to HSC, the hematopoietic microenvironments, and humoral regulators of blood cell production. The possibility that HIV-1 infection of HSC or progenitors occurs has been investigated by direct infection of purified CD34 cells in vitro [43, 44] . Nevertheless, some of the in vitro and in vivo studies have given conflicting results, and several studies demonstrated that CD34 cells are not infectible with HIV-1 [45] [46] [47] [52] [53] [54] . Functional changes in HSC, infected or uninfected by HIV-1, have been observed in some laboratories that used cells from patients with AIDS and cells from HIV-1-seronegative persons infected with HIV-1 in vitro [41, 42] . Similarly, investigations of HIV-1 infection of cells supporting HSC proliferation and differentiation resulted in conflicting conclusions [55] [56] [57] [58] . Moreover, humoral factors may also be responsible for the inhibition of hematopoiesis in patients with AIDS [39, 40] . These results suggested that complicated, multiple factors may be involved in the suppression of hematopoiesis in HIV-1-infected persons.
First, we sought to evaluate the moieties expressed on HSC that might be used for HIV-1 infection. By use of an in vitro liquid culture system, in which CD34 cells underwent prolif- after induction). HIV-1 p24 antigen expression was analyzed after different times after challenge ( after challenge). S ϭ days D ϭ days eration and differentiation along myeloid cell lineages, the kinetic changes in CD34, CD4, CXCR-4, and CCR-5 expression, at both the mRNA and protein cellular membrane levels, were investigated by RT-PCR and flow cytometric analysis. Some differences observed between protein levels on cellular membranes and concomitant mRNA expression (e.g., CXCR-4; figures 3, 5) may suggest that cell lineage-specific antigens, which are undetectable on the CD34 cell surface, can be expressed only when these stem cells are differentiated into specific cell types [59, 60] . Differences between RT-PCR and flow cytometric analysis in the assays of CD34 cell markers were also observed by others [61] . CD34 cells express only a few known detectable surface markers, and most of these will be lost and others will be acquired when the stem cells undergo proliferation and differentiation [60, 62] . CD34 expression quickly disappeared from these cells in our experiments, after induction, and may represent the loss of stem cell characteristics. Expression of the cell lineage-specific marker, CD4, occurred on the more fully induced cells, which may suggest that it is expressed on the fully matured macrophages, although its mRNA expression could be detected in the samples after shorter periods of induction ( figure 3 ). The b-chemokine coreceptor, CCR-5, was expressed on a certain type of cell, which was demonstrated to be a macrophage ( figure 6 ). The percentage of the cells expressing CCR-5 in the cultures did not increase after a relatively short period of induction, suggesting that CD34 cells differentiated into cells expressing CCR-5 soon after induction by HGFs. The a-chemokine receptor, CXCR-4, was also expressed by monocyte/macrophages as determined by both RT-PCR and flow cytometry (figures 3, 4). It has been well-documented that the proliferation and differentiation of HSC in vitro is completely controlled by the type and quantity of HGFs added in culture [63, 64] . Our culture conditions allow CD34 cells to proliferate and differentiate mainly into granulocytes, monocytes, and macrophages. The cell types expressing chemokine receptors, CXCR-4 and CCR-5, were cells morphologically demonstrated to be macrophages ( figure 6 ). It has been demonstrated that these coreceptors are specifically bound to viral envelope glycoproteins of T-and Mtropic strains of HIV-1, respectively, in the presence of CD4 [4, 20, 23] . The relationships between HIV-1 coreceptors and HIV-1 infectivity and between receptor expression and HIV-1 infectivity were analyzed by viral challenges of CD34 cells after induction for different time periods. We demonstrated, from our representative experimental results, that CXCR-4 expression on CD34 cell-derived progeny was insufficient for T-tropic isolate entry (figures 7, 8) . Only the background levels of HIV-1 Gag p24 protein could be detected after the CD34 cells and their differentiated progeny were challenged with the T-tropic isolate, NL . It seems reasonable that low levels of expression of CD4 were insufficient for T-tropic virus entry, if CD4 was expressed on the same type of cells expressing CXCR-4 [23] , although other molecular mechanisms may explain these findings. Further experiments to demonstrate if CXCR-4 is clearly expressed on the same cells expressing CD4, or possibly expressed on other subtypes of macrophages, will be helpful for understanding the mechanisms inhibiting T-tropic viral infection of CD34 cells and their differentiated progeny.
In contrast, the M-tropic virus, BaL, could efficiently infect CD34 cell-derived progeny and most likely used the b-chemokine coreceptor, CCR-5, and low levels of CD4 expressed on these cells for its entry. Interestingly, a direct relationship could be found between HIV-1 BaL infection and the level of coreceptor expression. CD34 cells, before induction, could not be infected by BaL at low virus input (figure 7). These results are in good correlation with the studies illustrated, in that CD34 cells do not express functional HIV-1 receptor and coreceptors (figure 5). CD34 cells before induction could be infected, albeit inefficiently, by high input of BaL, and this may due to contamination of CD34 cell samples with low levels of other cell types. As such, our studies also lend credence to the previous data suggesting that HSC are difficult to infect with HIV-1 in vitro or in vivo [46, 47] , although this remains controversial.
Our results demonstrated that highly purified human CD34 cells from UCB do not express the cell membrane receptor, CD4, nor coreceptors, CXCR-4 and CCR-5, used for HIV-1 entry. These data suggest the molecular basis for the inability of HIV-1 to infect CD34 cells in these stem cell populations. Moreover, HIV-1 infection of CD34 cell-derived progeny depends on the functional expression of the corresponding HIV-1 receptor and/or coreceptors. Low-level expression of CD4 may be sufficient for M-tropic strains, rather than T-tropic strains, to infect CD34 cell-derived monocyte/macrophages. Dynamic alterations of chemokine levels on the cell membrane, with a constant low level of CD4, may indicate that interactions of CD4 with CCR-5 and/or CXCR-4 are dependent not only on quantitative levels but also on colocalization of these moieties on the cell surface.
We analyzed the CD34 cells from UCB in "bulk." As such, there may be small subpopulations of stem cells from UCB that may interact with HIV-1 in differing ways. Nevertheless, this isolation technique is commonly used to obtain peripheral stem cells for gene therapeutics, and therefore, these studies have bearing on these therapeutic approaches [65, 66] . As there may also be differences in chemokine receptors and chemokines between bone marrow-derived CD34 cells and peripheral UCB CD34 cell types, further studies are required in other stem cell populations. Of note, the a-chemokine, SDF-1, which binds to CXCR-4, appears to be critical for CD34 stem cell development in the bone marrow but not in the fetal liver [67] .
A recent very brief study demonstrated that the mRNA for CXCR-4 was present in CD34 cells more commonly than was the mRNA for CCR-5 [68] . This agrees with our expanded findings in the present study. Nevertheless, that study used peripheral blood stem cells from oncology patients treated with chemotherapy, whereas our study used stem cells from the umbilical veins of normal, healthy infants. The work of Deichmann et al. [68] evaluated only mRNA and not protein levels of the chemokine receptors. The present studies demonstrated a dissynchrony between mRNA and protein levels of CXCR-4 in CD34 cells at baseline. As such, the conclusion of those investigators that CD34 cells may be potential targets for HIV-1 is not supported by more detailed analyses. In addition, our present studies evaluate stem cells temporally during differentiation and use viral infectivity experiments, neither of which was done by Deichmann et al. [68] .
Of note, new chemokine receptors are being described as coreceptors for various strains of HIV-1 [69, 70] . Further studies will be required to analyze the importance of other coreceptors for infection of CD34 stem cells and their progeny by HIV-1.
Several studies have shown that the vast majority of CD4 T lymphocytes in HIV-1-infected persons are present in lymph nodes [71] [72] [73] and not in the peripheral blood stream. Yet, levels of peripheral blood CD4 T lymphocytes decrease as disease develops, while lymph nodes may demonstrate enlargement. Studies of simian immunodeficiency virus-infected macaques have indicated enhanced homing of lymphocytes into lymph nodes [74] . As functional studies of human chemokines have illustrated their role in blood cell homing to specific tissues, further understanding of CXCR-4 and CCR-5 expression and regulation in human stem cells and their progeny may help elucidate the molecular mechanism(s) of HIV-1 infectionrelated hematopoietic abnormalities.
The present studies suggest that differentiation of CD34 stem cells occurs with distinct alterations of cell surface moieties critical for HIV-1 infection. As such, these data suggest potential stages of CD34 cell differentiation that may correlate with in vivo HIV-1 infection.
